Stock listing
Huadong Medicine Co., Ltd. Class A
Selected listing: 000963 · SZSE · CNY · CN
Huadong Medicine Co., Ltd. Class A (Shenzhen:000963), Health Technology. Latest release Mar 6, 2026: CARsgen Therapeutics Announces 2025 Annual Results.
- Ticker
- Shenzhen:000963
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Shenzhen
- Currency
- CNY
About Huadong Medicine Co., Ltd. Class A
The company is involved in the pharmaceutical industry, focusing on the development and production of various medical products. As a significant player in its sector, Huadong Medicine aims to enhance healthcare solutions within the market.
Latest news from Huadong Medicine Co., Ltd. Class A
CARsgen Therapeutics Announces 2025 Annual Results
March 6, 2026
Chance Pharma Announces Commercialization Agreement with Huadong Medicine for Innovative Respiratory Drug CXG87
October 9, 2025
Huadong Medicine Announces Positive Preliminary Results from a Phase Ⅰ study of HDM2005, a ROR1-Targeting ADC
September 5, 2025
Vcare Enters into Exclusive Partnership with Huadong Medicine to Commercialize its second-generation JAK1 inhibitor, VC005 tablets, in China
August 15, 2025
CARsgen Therapeutics Announces 2025 Interim Results
August 13, 2025
Research Huadong Medicine Co., Ltd. Class A
Huadong Medicine Co., Ltd. Class A company profile
View the public company page for Huadong Medicine Co., Ltd. Class A on 6ix.
Huadong Medicine Co., Ltd. Class A news
Read company news and market updates connected to Huadong Medicine Co., Ltd. Class A.
Huadong Medicine Co., Ltd. Class A investor events
Find investor webinars, events, and replay context for Huadong Medicine Co., Ltd. Class A.